Annual bill for NHS’s most costly drug set to be slashed

By Henry Anderson2025-08-03T07:37:00

The annual cost of NHS diabetes care could fall by £300m after the Supreme Court refused to consider blocking the introduction of a generic alternative to a widely used drug.

You need to be a subscriber to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All HSJ news by sector, topic & region
Breaking News announcements
App for mobile and offline reading
Comment and Daily Insights newsletters
Regional roundup newsletters
10 expert briefings every fortnight (Premium only)
Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)

to HSJ

Already a subscriber? Sign into your account here